Article Details

VBI Vaccines (NASDAQ:VBIV) Raised to Hold at Zacks Investment Research

Retrieved on: 2021-01-21 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

VBI Vaccines (NASDAQ:VBIV) Raised to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 117,546 shares of the biopharmaceutical company's stock worth $336,000 after buying an additional 91,943 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo